| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4001974 | American Journal of Ophthalmology | 2015 | 12 Pages |
Abstract
Seven years after initiation of intensive ranibizumab therapy for exudative age-related macular degeneration, macular atrophy progression and severity were the primary anatomic determinants of visual outcomes.
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
Robert B. Bhisitkul, Thais S. Mendes, Soraya Rofagha, Wayne Enanoria, David S. Boyer, SriniVas R. Sadda, Kang Zhang,